ODPM is a rare disease and its pathogenesis is not entirely clear. The management of ODPM is still challenging for the vitreoretinal surgeons. Since significant visual loss was observed in the majority of untreated cases, numerous treatment methods have been applied for the ODPM [6]. None of them have been identified as the gold standard treatment. Nowadays, the predominant approach for ODPM management is PPV especially in patients with vitreomacular traction [7]. Several authors have reported the results of PPV, in combination with gas tamponade, endolaser photocoagulation, silicone oil tamponade, internal limiting membrane (ILM) peeling or subretinal fluid drainage [18–22]. These studies have shown that PPV gives very encouraging long-term anatomical, functional outcomes and patients have satisfactory postoperative visual acuity results [18, 21, 23]. Nevertheless, the potential complications of PPV, including cataracts, retinal tear and retinal detachment, should be taken into consideration [24, 25].
Recently, in the meta-analysis of Zheng et al, six different surgical procedures including PPV alone, PPV with laser photocoagulation, PPV with ILM peeling, PPV with both ILM peeling and laser photocoagulation, PPV with inner retinal fenestration, and PPV with autologous platelet concentrate have been evaluated in the treatment of patients with ODPM [26]. The authors have investigated visual acuity changes, serous macular reattachment rate, reattachment time and macular thickness changes by OCT and it was reported that they have not found any significant difference in functional outcomes among these six surgical procedures.
Intravitreal gas tamponade facilitates dissection of the posterior hyaloid. The prone position allows subretinal fluid to be absorbed and the retinal pigment epithelium to attach to the sensory retina. Akiyama et al. used intravitreal gas tamponade alone in patients with ODPM [27]. They reported that, only 4 out of 8 eyes had achieved complete resolution of intra-subretinal fluids. Also, repeated intravitreal gas injection was performed in 3 of these 4 eyes. Laser photocoagulation alone was also used for the treatment in patients with ODPM but the results were not very promising [28, 29]. In addition to the intravitreal gas tamponade treatment, laser photocoagulation can block the abnormal junction between ODP and adjacent subretinal space. When they are applied together, the gas also keeps neural retina and pigment epithelium in contact near the optic nerve head to allow the laser spots to create adhesion. Therefore, it plays a critical role in reducing fluid flow from ODP to macular region [16].
Lei et al. reported that they achieved complete retinal reattachment in 7 out of 9 eyes with intravitreal C3F8 tamponade combined with laser photocoagulation. Repeated treatment was required in 3 of these eyes. In addition, visual improvement and significant fluid decrease were observed in the other 2 eyes [16]. Elmohamady et al. also applied intravitreal sulphur hexafluoride (SF6) gas tamponade combined with laser photocoagulation in patients with ODPM. They reported that the treatment resulted in complete resolution of subretinal fluid in all of the patients. Repeated injections were required in 2 of the 11 eyes. In addition, they observed no recurrence in any of the patients during the follow-up period [17].
In the present study, after the intravitreal C3F8 gas tamponade combined with prone position and laser photocoagulation treatment procedure, complete retinal reattachment was achieved in 4 of 6 patients. Furthermore, serous macular detachment and retinoschisis-like changes decreased in 5 of 6 patients. Patient 6 showed a significant decrease in the serous macular detachment and his BCVA improved within 4 months of follow-up. As reported previously, a long follow-up period may be required to achieve complete retinal reattachment in some patients with ODPM. It has been observed that complete retinal attachment may take up to 18 months [16]. When the follow-up time is extended in patient 6, more acceptable treatment results are likely to be achieved.
In patient 3, because no regression was observed after the second intravitreal gas tamponade injection, PPV was performed. The reason for the failure of the technique in this patient may depend on two factors. Firstly, the age of the patient might have affected the success considering that the patient 3 was the oldest patient (age; 66) in our case series. It has been demonstrated that younger patients may have a higher chance of success in our treatment procedure [17]. She presented with asthenopic complaints and the diagnosis was made incidentally. She did not recognize the vision loss in her eye. Probably, serous macular detachment and retinoschisis-like changes had been present for a long time. Lee et al. have supported that the delayed treatment is associated with poor anatomic and functional outcomes [16].
We have informed our patients about the benefits and complications of PPV and intravitreal gas tamponade combined with laser photocoagulation treatment procedure. In our cases, ODPM patients have preferred this procedure before PPV due to it is less invasive and has a relatively low complication rate. They have chosen PPV to be performed in the second stage in case of failure. The choice of secondary PPV can be considered reasonable because almost all of our patients did not have vitreomacular or vitreopapillary traction. However, PPV surgery was performed in one patient because no improvement was observed despite repeated treatment. Since ODPM is a rare disease, it is difficult to conduct a randomized controlled trial with a large case series. Nevertheless, the results of our study show that the anatomical and visual results of intravitreal C3F8gas tamponade combined with laser photocoagulation treatment are encouraging and this procedure can be performed under topical anesthesia confidently.